MOH — authorised 8 November 2013
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: likely_approved
🇮🇱 Aptiom in Israel
MOH authorised Aptiom on 8 November 2013
Marketing authorisation
Aptiom in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Israel
Frequently asked questions
Is Aptiom approved in Israel?
Yes. MOH authorised it on 8 November 2013.
Who is the marketing authorisation holder for Aptiom in Israel?
SUNOVION PHARMS INC holds the Israeli marketing authorisation.